BlackRock’s Dogwood Therapeutics DWTX Stock Holding History

BlackRock’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63	Hold	30	–	–	﹤0.01%	5627
2025 Q4	$125	Hold	30	–	–	﹤0.01%	5471
2025 Q3	$231	Hold	30	–	–	﹤0.01%	5387
2025 Q2	$143	Hold	30	–	–	﹤0.01%	5406
2025 Q1	$150	Hold	30	–	–	﹤0.01%	5374
2024 Q4	$75	Hold	30	–	–	﹤0.01%	5356
2024 Q3	$128	Hold	30	–	–	﹤0.01%	5180
2024 Q2	$162	Hold	30	–	–	﹤0.01%	5238
2024 Q1	$362	Hold	30	–	–	﹤0.01%	5228
2023 Q4	$434	Hold	30	–	–	﹤0.01%	5292
2023 Q3	$698	Hold	30	–	–	﹤0.01%	5343
2023 Q2	$1.04K	Sell	30 -1,594	-98%	-$45.5K	﹤0.01%	5405
2023 Q1	$14.9K	Buy	1,624 +54	+3%	+$429	﹤0.01%	5284
2022 Q4	$9.26K	Buy	1,570 +36	+2%	+$271	﹤0.01%	5468
2022 Q3	$15K	Buy	1,534 +926	+152%	+$130K	﹤0.01%	5555
2022 Q2	$65K	Sell	608 -103	-14%	-$10.8K	﹤0.01%	5360
2022 Q1	$80K	Sell	711 -35	-5%	-$5.09K	﹤0.01%	5332
2021 Q4	$95K	Buy	746 +112	+18%	+$14.2K	﹤0.01%	5286
2021 Q3	$84K	Buy	634 +248	+64%	+$34.3K	﹤0.01%	5180
2021 Q2	$61K	Buy	386 +357	+1,231%	+$50.6K	﹤0.01%	5156
2021 Q1	$4K	Buy	+29	New	+$5.05K	﹤0.01%	5164

Other funds holding DWTX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

BlackRock's DWTX Position: Q1 2026 in Review

BlackRock held its Dogwood Therapeutics (DWTX) position steady in Q1 2026 at 30 shares worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #5627.

BlackRock first reported a position in DWTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $95K in Q4 2021. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

BlackRock held 30 shares of Dogwood Therapeutics worth $63 as of Q1 2026.
BlackRock left its Dogwood Therapeutics share count unchanged in Q1 2026.
Dogwood Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5627 holding.
BlackRock first reported a position in Dogwood Therapeutics in Q1 2021 and has held it in 21 quarters since.
BlackRock's Dogwood Therapeutics position peaked at $95K in Q4 2021.
13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.